Roux-en Y gastric bypass surgery induces genome-wide promoter-specific changes in DNA methylation in whole blood of obese patients

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Nilsson, Emil K ^a   Ernst, Barbara ^b   Voisin, Sarah ^a   Almén, Markus Sällman ^a   Benedict, Christian ^a   Mwinyi, Jessica ^a   Fredriksson, Robert ^b   Schultes, Bernd ^b   Schiöth, Helgi B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Interdisciplinary Obesity Center eSwiss Medical and Surgical Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUCOSE;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENETIC PREDISPOSITION; GENOME ANALYSIS; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROMOTER REGION; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ADVERSE EFFECTS; GENETICS; HUMAN GENOME; MIDDLE AGED;

ADULT; ANASTOMOSIS, ROUX-EN-Y; DNA METHYLATION; FEMALE; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; OBESITY; PROMOTER REGIONS, GENETIC;

EID: 84923360658     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115186     Document Type: Article

References (21)

1. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, et al. (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292: 1724-1737. doi: 10.1001/jama.292.14.1724 PMID: 15479938
2. Adams TD, Davidson LE, Litwin SE, Kolotkin RL, LaMonte MJ, et al. (2012) Health benefits of gastric bypass surgery after 6 years. JAMA 308: 1122-1131. doi: 10.1001/2012.jama.11164 PMID: 22990271
3. Bojsen-Møller KN, Dirksen C, Jørgensen NB, Jacobsen SH, Hansen DL, et al. (2013) Increased Hepatic Insulin Clearance After Roux-en-Y Gastric Bypass. Journal of Clinical Endocrinology & Metabolism. doi: 10.1210/jc.2013-1286
4. Dixon JB, le Roux CW, Rubino F, Zimmet P (2012) Bariatric surgery for type 2 diabetes. Lancet 379: 2300-2311. doi: 10.1016/S0140-6736(12)60401-2 PMID: 22683132
5. Yang BT, Dayeh TA, Kirkpatrick CL, Taneera J, Kumar R, et al. (2011) Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia 54: 360-367. doi: 10.1007/s00125-010-1967-6 PMID: 21104225
6. Kouzarides T (2007) Chromatin Modifications and Their Function. Cell 128: 693-705. doi: 10.1016/j.cell.2007.02.005 PMID: 17320507
7. Almen MS, Jacobsson JA, Moschonis G, Benedict C, Chrousos GP, et al. (2012) Genome wide analysis reveals association of a FTO gene variant with epigenetic changes. Genomics 99: 132-137. doi: 10.1016/j.ygeno.2011.12.007 PMID: 22234326
8. Xu X, Su S, Barnes VA, De Miguel C, Pollock J, et al. (2013) A genome-wide methylation study on obesity: Differential variability and differential methylation. Epigenetics 8. doi: 10.4161/epi.24506 PMID: 23644594
9. Kirchner H, Nylen C, Laber S, Barres R, Yan J, et al. (2014) Altered promoter methylation of PDK4, IL1 B, IL6, and TNF after Roux-en Y gastric bypass. Surg Obes Relat Dis.
10. Fried M, Hainer V, Basdevant A, Buchwald H, Deitel M, et al. (2007) Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes (Lond) 31: 569-577.
11. Sambrook J FE, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory press.
12. Team Rc (2012) R: A Language and Environment for Statistical Computing.
13. Wang D, Yan L, Hu Q, Sucheston LE, Higgins MJ, et al. (2012) IMA: an R package for high-throughput analysis of Illumina0 s 450K Infinium methylation data. Bioinformatics 28: 729-730. doi: 10.1093/bioinformatics/bts013 PMID: 22253290
14. Hsieh CL (1994) Dependence of transcriptional repression on CpG methylation density. Mol Cell Biol 14: 5487-5494. PMID: 7518564
15. Kirchner H, Osler ME, Krook A, Zierath JR (2013) Epigenetic flexibility in metabolic regulation: disease cause and prevention? Trends Cell Biol 23: 203-209. doi: 10.1016/j.tcb.2012.11.008 PMID: 23277089
16. Baumer N, Tickenbrock L, Tschanter P, Lohmeyer L, Diederichs S, et al. (2011) Inhibitor of cyclin-dependent kinase (CDK) interacting with cyclin A1 (INCA1) regulates proliferation and is repressed by oncogenic signaling. J Biol Chem 286: 28210-28222. doi: 10.1074/jbc.M110.203471 PMID: 21540187
17. Adams TD, Stroup AM, Gress RE, Adams KF, Calle EE, et al. (2009) Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring) 17: 796-802. doi: 10.1038/oby.2008.610
18. Arias AM, Bisschop PH, Ackermans MT, Nijpels G, Endert E, et al. (2001) Aminophylline stimulates insulin secretion in patients with type 2 diabetes mellitus. Metabolism 50: 1030-1035. doi: 10.1053/meta. 2001.25800 PMID: 11555834
19. Rusing D, Muller CE, Verspohl EJ (2006) The impact of adenosine and A(2B) receptors on glucose homoeostasis. J Pharm Pharmacol 58: 1639-1645. doi: 10.1211/jpp.58.12.0011 PMID: 17331328
20. Chapal J, Loubatieres-Mariani MM, Petit P, Roye M (1985) Evidence for an A2-subtype adenosine receptor on pancreatic glucagon secreting cells. Br J Pharmacol 86: 565-569. doi: 10.1111/j.1476-5381.1985.tb08932.x PMID: 2998522
21. Barres R, Kirchner H, Rasmussen M, Yan J, Kantor FR, et al. (2013) Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep 3: 1020-1027. doi: 10.1016/j.celrep.2013.03.018 PMID: 23583180